N-Nitroso Palbociclib

Status: In-stock

N-Nitroso Palbociclib is an impurity present in Palbociclib, Palbociclib highly selective cyclin-dependent kinase 4/6 inhibitor, Palbociclib in combination with endocrine therapy is a valuable emerging option for patients with HR+/HER2− advanced or metastatic breast cancer.

Additional information on N-Nitroso Palbociclib

Catalogue No. VE009744
Molecular Formula C24H28N8O3
Molecular Weight 476.53 g/mol
Parent drug Palbociclib
IUPAC Name 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(4-nitrosopiperazin-1-yl)pyridin-2-yl)amino)pyrido[2, 3-d]pyrimidin-7(8H)-one
Synonyms N/A
References Serra, F., Lapidari, P., Quaquarini, E., Tagliaferri, B., Sottotetti, F., & Palumbo, R. (2019). Palbociclib in metastatic breast cancer: current evidence and real-life data. Drugs in Context, 8, 1–16. https://doi.org/10.7573/dic.212579
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

N-Nitroso Palbociclib

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.